In the present study, we provide novel data that strongly point to NF-κB nuclear translocation (ie activation) as a late event in prostate cancer development and also that nuclear NF-κB expression is an independent predictor of a significantly increased risk of biochemical (PSA) relapse in patients that underwent prostatectomy. Here, NFKB1 is linked to prostate cancer.